ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 350 filers reported holding ARGENX SE in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $5,636,543 | -5.6% | 14,346 | -8.6% | 0.00% | -20.0% |
| Q4 2023 | $5,971,990 | +28.7% | 15,698 | +66.4% | 0.01% | 0.0% |
| Q3 2023 | $4,639,021 | +7.2% | 9,436 | -15.0% | 0.01% | +25.0% |
| Q2 2023 | $4,327,172 | +4.6% | 11,103 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $4,136,756 | +7.9% | 11,103 | +9.7% | 0.01% | +25.0% |
| Q4 2022 | $3,834,517 | +13.1% | 10,122 | +5.4% | 0.00% | -33.3% |
| Q3 2022 | $3,389,000 | +8.6% | 9,600 | +16.5% | 0.01% | +50.0% |
| Q2 2022 | $3,122,000 | – | 8,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
| Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
| Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
| MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
| AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
| EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
| INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
| Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
| DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
| Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |